Literature DB >> 30597253

Feeding-regimen of β-glucan to enhance innate immunity and disease resistance of Nile tilapia, Oreochromis niloticus Linn., against Aeromonas hydrophila and Flavobacterium columnare.

Soraat Amphan1, Sasimanas Unajak2, Cheewarat Printrakoon3, Nontawith Areechon4.   

Abstract

β-glucan is one of the most potent immunostimulants enhancing innate immune activity, disease resistance and growth performance of many aquatic organisms. Nevertheless, there are few studies on feeding regimens of β-glucan that correlate to immune response and disease resistance and are important considerations for practical β-glucan utilization. Thus, the effect of β-glucan and feeding duration on innate immunity and disease resistance was investigated to establish an optimal feeding regimen of β-glucan for Nile tilapia (Oreochromis niloticus Linn.). A variety of β-glucan feeding regimens were evaluated, including: i) feeding for 2 weeks, ii) feeding for 4 weeks, and iii) feeding every-other-week, with the objective of establishing the optimal feeding regimen that enhanced innate immunity and disease resistance. Innate immunity parameters were determined every week for eight weeks. Alternative complement activity of all β-glucan groups was significantly (P < 0.05) increased at the end of the first week, and then fluctuated but was not significantly (P > 0.05) different to the control until the end of the trial. Increased lysozyme activity was only detected at the end of the second week in all β-glucan-treated groups, and then decreased to the control level during most of the sampling periods. Phagocytosis percentage was increased and prolonged by β-glucan feeding, while the phagocytic index was not. Apart from innate immunity, β-glucan-fed fish demonstrated enhanced disease resistance against Aeromonas hydrophila and Flavobacterium columnare challenge at only the end of the fourth week of the trial. The growth performance of β-glucan-fed fish was not significantly (P > 0.05) different among the experimental groups and control. Taken together, the result indicated that all β-glucan-feeding regimens resulted in quite similar outcomes with respect to innate immunity stimulation, disease resistance and growth performance. This novel result suggests that an every-other-week regimen is the optimal choice for Nile tilapia cultivation as an economic cost saving benefit. This is the first study to determine the optimal feeding-regimen of β-glucan to enhance innate immunity and increase resistance to infection by pathogenic bacteria in Nile tilapia.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aeromonas hydrophila; Flavobacterium columnare; Innate immunity; Nile tilapia; β-glucan

Mesh:

Substances:

Year:  2018        PMID: 30597253     DOI: 10.1016/j.fsi.2018.12.062

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  4 in total

1.  Supplementation of Dietary Crude Lentinan Improves the Intestinal Microbiota and Immune Barrier in Rainbow Trout (Oncorhynchus mykiss) Infected by Infectious Hematopoietic Necrosis Virus.

Authors:  Guangming Ren; Liming Xu; Jingzhuang Zhao; Yizhi Shao; Xiaoyu Chen; Tongyan Lu; Qiya Zhang
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

2.  Growth performance and hemato-immunological responses of Nile tilapia (Oreochromis niloticus) exposed to deltamethrin and fed immunobiotics.

Authors:  Mahmoud A O Dawood; Marwa F AbdEl-Kader; Eman M Moustafa; Mahmoud S Gewaily; Safaa E Abdo
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-22       Impact factor: 4.223

Review 3.  Yeast β-Glucans as Fish Immunomodulators: A Review.

Authors:  Cristian Machuca; Yuniel Méndez-Martínez; Martha Reyes-Becerril; Carlos Angulo
Journal:  Animals (Basel)       Date:  2022-08-22       Impact factor: 3.231

4.  Dietary supplementation of Nile tilapia (Oreochromis niloticus) with β-glucan and/or Bacillus coagulans: Synergistic impacts on performance, immune responses, redox status and expression of some related genes.

Authors:  Ahmed F Fath El-Bab; Kamlah A Majrashi; Huda M Sheikh; Manal E Shafi; Ibrahim T El-Ratel; Ahmed N F Neamat-Allah; Ali A El-Raghi; Amar Y Abd Elazem; Mohamed F Abd-Elghany; Sameh A Abdelnour; Maisa S Abduh; Mariusz Jaremko; Mohammed A E Naiel
Journal:  Front Vet Sci       Date:  2022-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.